Tower Research Capital (TRC)’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-22,982
| Closed | -$6K | – | 6586 |
|
|
2023
Q1 | $6K | Buy |
22,982
+14,039
| +157% | +$3.67K | ﹤0.01% | 4920 |
|
|
2022
Q4 | $11K | Buy |
8,943
+2,157
| +32% | +$2.65K | ﹤0.01% | 3930 |
|
|
2022
Q3 | $14K | Buy |
+6,786
| New | +$14K | ﹤0.01% | 4244 |
|
|
2022
Q2 | – | Sell |
-728
| Closed | -$4K | – | 6839 |
|
|
2022
Q1 | $4K | Sell |
728
-4,529
| -86% | -$24.9K | ﹤0.01% | 5306 |
|
|
2021
Q4 | $33K | Buy |
5,257
+4,262
| +428% | +$26.8K | ﹤0.01% | 3157 |
|
|
2021
Q3 | $10K | Buy |
+995
| New | +$10K | ﹤0.01% | 4377 |
|